Navigation Links
VIB&CD3 enter into license and collaboration agreement with AstraZeneca for development of MALT1 inhibitor
Date:1/31/2014

Leuven/Gent (Belgium), 31 January 2014 VIB and CD3 (KU Leuven) today announced the signing of a license and collaboration agreement with AstraZeneca for the development of novel MALT1 inhibitors as therapeutics in inflammatory and oncological diseases.

The research teams of Thijs Baens and Peter Marynen (VIB-KU Leuven, Center for Human Genetics) and Rudi Beyaert (VIB-UGent, Inflammation Research Center) were among the first to identify MALT1, an important regulator of the NF-κB signaling pathway and demonstrate its proteolytic activity on some key substrates. Since then, the proteolytic activity of MALT1 has emerged as a promising target for treatment of auto-immune disorders and certain types of cancer. VIB and CD3 launched a joint early drug discovery collaboration to identify small molecule MALT1 protease inhibitors, which now results in a license to AstraZeneca.

AstraZeneca aims to further develop the small molecule MALT1 inhibitors and, as part of the deal, the parties will join forces in an R&D collaboration to further investigate this interesting target. Both teams will undertake work outlined in the joint research plan .

Under the terms of the agreement, AstraZeneca will make an upfront payment and milestone payments based upon the achievement of development and regulatory goals. VIB and CD3 (KU Leuven) are eligible to receive royalty payments on future products developed under the agreement.

Johan Cardoen, Managing Director of VIB commented "We are very pleased with this license deal and strategic collaboration, bringing together top biological research, industry-standard early drug development and, now, a top notch industrial partner like AstraZeneca to give the program the best possible chances of success. This deal illustrates the potential of translating excellence-driven biological research into actual therapies for patients in need."

"It is great to see that the combination of the important a
'/>"/>

Contact: Kris Van der Beken
kris.vanderbeken@vib.be
32-473-783-435
VIB (the Flanders Institute for Biotechnology)
Source:Eurekalert

Page: 1 2

Related biology news :

1. UK establishes 3 new synthetic biology research centers
2. £3m drug safety center investment
3. FAK helps tumor cells enter the bloodstream
4. Museum bird DNA ready for use in Naturalis Biodiversity Center
5. Eurofins and Orion Diagnostica Oy enter into an agreement on Orions proprietary SIBA technology
6. Uganda Heart Institute physicians and nurses visit Texas Childrens Heart Center
7. Army renews bio-inspired engineering and science research center at UC Santa Barbara with $48 million
8. Data centers can be cooled down in environmentally friendly, energy efficient ways
9. DFG establishes 9 new collaborative research centers
10. Wilson Center awarded European Union grant for synthetic biology work
11. Wake Forest Baptist Medical Center and Cornerstone Health Care Join in Unique Affiliation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... such as the prolific bloomer Emiliania huxleyi , ... discovered. The finding contradicts the common view that ... on scarce supplies of thiamine in the ocean to ... about the ocean," says CIFAR Senior Fellow Alexandra ... paper with CIFAR fellows John Archibald (Dalhousie ...
(Date:8/28/2014)... pleased to announce the selection of Dr. Fred Baxendale ... acknowledges those who have served ESA for at least ... the Society that has reached an extraordinary level. Candidates ... Board and then voted on by the ESA membership. ... at Entomology 2014, ESA,s Annual Meeting in Portland, Oregon ...
(Date:8/28/2014)... to Research Careers) Program has announced the travel award ... October 18 22, 2014 in San Diego, California. ... of students, post doctorates and scientists from underrepresented groups ... to encourage the participation of young scientists at the ... conferred 16 awards totaling $29,600., The FASEB MARC Program ...
Breaking Biology News(10 mins):Not all phytoplankton in the ocean need to take their vitamins 2Not all phytoplankton in the ocean need to take their vitamins 3Fred Baxendale selected as Honorary Member of the Entomological Society of America 2
... More than 2,000 former football players are suing the National ... to deal with injuries related to concussions more seriously. ... warrants criticism, the NFL isn,t the only player deserving a ... law expert David Orentlicher, who teaches at Indiana University Robert ...
... , Fraunhofer researchers are exhibiting how renewable, biodegradable ... interior design and the packaging industry at this year,s ... 27 (Hall 5.2a, Booth 103). They consist of ... and diatomaceous earth, a material that is procured from ...
... University of Toronto Scarborough researchers gives the best description ... mental illness called Borderline Personality Disorder (BPD), and could ... shows that brain regions that process negative emotions (for ... BPD, while brain regions that would normally help damp ...
Cached Biology News:Fraunhofer shows bio-tiles and heat-resistant biopolymers 2New insights into the 'borderline personality' brain 2
(Date:8/29/2014)... Boston, MA (PRWEB) August 29, 2014 Due ... (FRC) last week, the Adult Stem Cell Technology Center, ... donations to support stem cell therapy research that might benefit ... adult stem cells for new stem cell technologies and therapeutic ... ALS Ice Bucket Challenge donors who wish not ...
(Date:8/28/2014)... 2014 Best Sanitizers, Inc., a leader ... processing industry, is asking industry professionals to prepare for ... the E2 soap they’re currently using to the Best ... Hand hygiene is critical to fighting cross-contamination and ... Six key criteria are identified to evaluate the effectiveness ...
(Date:8/28/2014)... important devices in spintronics, an electronic which is ... but also on their spin and the spin-related ... into magnetic signals and vice versa. Recently, the ... Institute of Physics at Johannes Gutenberg University Mainz ... and Japan, has for the first time realised ...
(Date:8/28/2014)... SunTrust Robinson Humphrey (STRH) today announced the ... research team in biotechnology and oilfield services.  ... demonstrates our commitment to providing our valued institutional ... decision making," said Biff Woodruff , Head ... significant investments in differentiated content at a time ...
Breaking Biology Technology:The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3Best Sanitizers, Inc. Asks Food Industry Professionals: With Fall Harvest On the Way, Is Your E2 Hand Soap Up to the Task? 2A new, tunable device for spintronics 2A new, tunable device for spintronics 3SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 2SunTrust Robinson Humphrey Expands Equity Research in Healthcare and Energy 3
... Two UK companies have been awarded joint funding for ... the quest to aid detection and eradication of Tuberculosis ... (NPL) and Orla Protein Technologies (Orla) have been awarded ... methods for the detection of TB. The ...
... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; ... var shortURL = ""; BitlyCB.alertResponse = function(data) { var s ... for (var r in data.results) { first_result = data.results[r]; break; } for (var key in first_result) { //s ...
... 27 ISTA Pharmaceuticals, Inc. (Nasdaq: ... REMURA™ (bromfenac ophthalmic solution for dry eye) Phase ... in the primary endpoint of the objective sign ... The study also achieved statistical significance on the ...
Cached Biology Technology:Nanobiotechnology experts join forces to improve TB testing 2Christopher Bowe Joins Scrip as US Healthcare Analyst 2Christopher Bowe Joins Scrip as US Healthcare Analyst 3Christopher Bowe Joins Scrip as US Healthcare Analyst 4Christopher Bowe Joins Scrip as US Healthcare Analyst 5Christopher Bowe Joins Scrip as US Healthcare Analyst 6Christopher Bowe Joins Scrip as US Healthcare Analyst 7ISTA Pharmaceuticals Highlights Clinical Data from REMURA™ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface 2ISTA Pharmaceuticals Highlights Clinical Data from REMURA™ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface 3ISTA Pharmaceuticals Highlights Clinical Data from REMURA™ Phase 2 Study Presented at the 6th International Conference on the Tear Film & Ocular Surface 4
...
... siSolutions siRNA Custom Synthesis Service ... duplex RNA to knockdown any ... (19 RNA base pairs with ... 27-mers, or other lengths of ...
Alexa Fluor 647 anti-mouse Qa-2...
... cDNA normalization is essential for hunting ... high-throughput approaches, such as EST sequencing ... Evrogen TRIMMER-DIRECT kit is developed for ... sequences and intended for directional cloning. ...
Biology Products: